top of page

Rapid CAR-T Platforms: A Top-level Analysis

CAR-T therapy has dramatically changed the course of cancer management over the past few years. However, despite this impact, one of the key challenges about the CAR-T therapies is its highly complex and long manufacturing process. With this lengthy manufacturing time and long wait-time, patients face higher chance of disease progression. To address this scenario, many novel platforms which promote rapid production of CAR-Ts are underway. Several steps utilized in conventional CAR-T production are bypassed and replaced with novel strategies to reduce time.

The current slide deck comprehensively summarizes such rapid CAR-T production platforms, the therapeutic areas that are being targeted and their development phase.

Please write to us at – 

  • To get a comprehensive analysis of each of these rapid CAR-T manufacturing platforms and details of all the rapid CAR-T assets

  • To access clinical outcomes of the CAR-T assets manufactured by the rapid CAR-T platforms

  • To understand other research strategies under investigation to improve the efficacy of CAR-T therapies

  • To get complete access to the landscape of CAR-Ts and other cell and gene therapies


bottom of page